BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3008801)

  • 1. Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4.
    Bauer FW; van de Kerkhof PC; Maassen-de Grood RM
    Br J Dermatol; 1986 Apr; 114(4):409-12. PubMed ID: 3008801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of intraepidermal microabscesses by topical application of leukotriene B4.
    Camp R; Jones RR; Brain S; Woollard P; Greaves M
    J Invest Dermatol; 1984 Feb; 82(2):202-4. PubMed ID: 6319504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
    Wong E; Camp RD; Greaves MW
    J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions.
    Seyger MM; van Pelt JP; van den Born J; Latijnhouwers MA; de Jong EM
    Arch Dermatol Res; 1997 May; 289(6):331-6. PubMed ID: 9209678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
    van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
    Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry.
    Glade CP; Botermans RJ; van Erp PE; van de Kerkhof PC
    Acta Derm Venereol; 1995 Nov; 75(6):437-41. PubMed ID: 8651019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
    de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
    Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
    van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
    Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraepidermal accumulation of polymorphonuclear leukocytes in annular pustular psoriasis.
    van de Kerkhof PC; Lammers AM
    Dermatologica; 1988; 176(6):282-7. PubMed ID: 2841175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo.
    Wiley HE; Weinstein GD
    J Invest Dermatol; 1979 Dec; 73(6):545-7. PubMed ID: 512406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the stratum corneum of uninvolved psoriatic skin abnormal?
    King CS; Nicholls S; Barton S; Marks R
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):95-100. PubMed ID: 294103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal proliferation and accumulation of polymorphonuclear leukocytes in the psoriatic lesion.
    Beurskens T; Chang A; van Erp PE; van de Kerkhof PC
    Dermatologica; 1989; 178(2):67-72. PubMed ID: 2924984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis.
    Hagemann I; Proksch E
    Acta Derm Venereol; 1996 Sep; 76(5):353-6. PubMed ID: 8891006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene B4-like material in scale of psoriatic skin lesions.
    Brain SD; Camp RD; Cunningham FM; Dowd PM; Greaves MW; Black AK
    Br J Pharmacol; 1984 Sep; 83(1):313-7. PubMed ID: 6091827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes.
    Kragballe K; Desjarlais L; Voorhees JJ
    Br J Dermatol; 1985 Jul; 113(1):43-52. PubMed ID: 2990516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous application of leukotriene B4 as an in vivo model of psoriasis-like skin inflammation: an immunohistological study.
    Hendriks AG; Keijsers RR; Seyger MM; van de Kerkhof PC; van Erp PE
    Skin Pharmacol Physiol; 2014; 27(3):120-6. PubMed ID: 24401330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
    Lammers AM; van de Kerkhof PC; Mier PD
    Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of the clinically uninvolved skin of psoriatic patients to repeated tape stripping during cyclosporin A treatment.
    Gerritsen MJ; Rulo HF; Arnold WP; Van de Kerkhof PC
    Br J Dermatol; 1994 Feb; 130(2):181-8. PubMed ID: 7510122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.